We are members of Pharmabiotic Research Institute and was specially invited to participate at this distinguished conference. With close to 110 companies representing big pharma, investors and (9 universities) much more this an event we don’t want to miss. 

The microbiome and its role in human health represents a paradigm shift in how medicines will be developed. Pharmabiotics Conference & Partnering brings together players from academia and industry to make Microbiome-based Drug Products a therapeutic reality. The scientific program is organized in such a way to reflect the R&D continuum, addressing each major phase of scientific advances, challenges and innovations across all stages of microbiome product development.

“The conference was very rewarding and in addition to the meetings, I got in touch with several other companies / individuals, all in our specific area. Milmed is starting to be recognized by more and more people and noticeably is an interest for us and our product”.

CEO Thomas Lenz